H-R^LNEVAKNL-OH

Rif. 3D-PP49308

Informazioni sul prodotto

• Nome: H-R^LNEVAKNL-OH

Descrizione

Peptide H-R^LNEVAKNL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-R^LNEVAKNL-OH include the following: The ORF8 Protein of SARS-CoV-2 Mediates Immune Evasion Y Zhang, J Zhang, Y Chen, B Luo, Y Yuan, F Huang - scholar.archive.orghttps://scholar.archive.org/work/3zrt2qg5azajlmkqeamsmwo3fm/access/wayback/https://www.biorxiv.org/content/biorxiv/early/2020/05/24/2020.05.24.111823.full.pdf The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι Y Zhang , Y Chen , Y Li, F Huang - Proceedings of the , 2021 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.2024202118 The ORF8 protein of SARS-CoV-2 mediates immune evasion through potently downregulating MHC-I Y Zhang , J Zhang, Y Chen , B Luo, Y Yuan, F Huang - biorxiv, 2020 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2020.05.24.111823.abstract COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A,-B,-C) across global populations Y Cun, C Li, L Shi, M Sun, S Dai, L Sun - Human Vaccines & , 2021 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/21645515.2020.1823777 A modified HLA-A* 0201-restricted CTL epitope from human oncoprotein (hPEBP4) induces more efficient antitumor responses W Sun, J Shi, J Wu, J Zhang, H Chen, Y Li - Cellular & Molecular , 2018 - nature.comhttps://www.nature.com/articles/cmi2017155 Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8+ CTL response by exosomes derived from IL-18 gene-modified CEA S Dai, X Zhou, B Wang, Q Wang , Y Fu, T Chen - Journal of molecular , 2006 - Springerhttps://link.springer.com/article/10.1007/s00109-006-0102-0 SARS immunity and vaccination M Zhu - Cell Mol Immunol, 2004 - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=9bbfa6d11ee1e0f34aee6618ce49985b987c7c67 Toward a SARS-CoV-2 VLP Vaccine: HBc/G as a Carrier for SARS-CoV-2 Spike RBM and Nucleocapsid Protein-Derived Peptides I Petrovskis, D Skrastina, J Jansons , A Dislers - Vaccines, 2024 - mdpi.comhttps://www.mdpi.com/2076-393X/12/3/267 Identification of an HLA-A*0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein B Wang, H Chen, X Jiang , M Zhang, T Wan , N Li - Blood, 2004 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/104/1/200/114452 Identification and characterization of an immunodominant SARS-CoV-2-specific CD8 T cell response A Gangaev, SLC Ketelaars, OI Isaeva , S Patiwael - 2020 - europepmc.orghttps://europepmc.org/article/ppr/ppr212194

• Marchio: Biosynth